MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
LXEO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lexeo Therapeutics (LXEO) Ownership - Who owns Lexeo Therapeutics?

Lexeo Therapeutics Inc is a clinical-stage genetic medicine company engaged in the development of gene therapy candidates targeting the underlying genetic causes of cardiovascular diseases... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
59
Web
https://www.lexeotx.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
395.75M
P/E Ratio
N/A
Total Cash
193.04M
Projected Growth
N/A
Total Debt
7.37M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.46
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
LXEO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for LXEO
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
345 Park Avenue South
Phone
+1 212 547-9879
Employees
59
Web
https://www.lexeotx.com